- Home
- ACIC vs NPCE Comparison
ACIC vs NPCE Comparison
Compare ACIC & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$14.73
Company Overview
Basic Information| Metric | ACIC | NPCE |
|---|---|---|
| Founded | 1999 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 625.2M | 514.3M |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ACIC | NPCE |
|---|---|---|
| Price | $11.27 | $14.73 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | N/A | ★ $18.33 |
| AVG Volume (30 Days) | ★ 305.5K | 147.8K |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | ★ 6.66% | N/A |
| EPS Growth | N/A | ★ 26.77 |
| EPS | ★ 1.61 | N/A |
| Revenue | ★ $296,657,000.00 | $79,906,000.00 |
| Revenue This Year | N/A | $25.95 |
| Revenue Next Year | $3.14 | $0.28 |
| P/E Ratio | $7.00 | ★ N/A |
| Revenue Growth | 3.53 | ★ 22.14 |
| 52 Week Low | $9.97 | $7.56 |
| 52 Week High | $13.06 | $18.97 |
Technical Indicators
Market Signals| Indicator | ACIC | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 54.51 | 44.22 |
| Support Level | $10.96 | $14.02 |
| Resistance Level | $11.93 | $16.96 |
| Average True Range (ATR) | 0.42 | 0.65 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 86.00 | 38.36 |
Price Performance
Historical Comparison ACIC
NPCE
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.